First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                         (Dr RN Tandon)
To Read the full story on emedinexus.com, or download our Android app or iOS app
11th May, 2017
ACP releases new guidelines on the treatment of osteoporosis
 
The American College of Physicians (ACP) has released new guidelines on the treatment of osteoporosis, which have been published in the Annals of Internal Medicine. The recommendations for treating osteoporosis were last published in 2008. 
  • Physicians should treat women with osteoporosis with bisphosphonates (alendronate, risedronate, or zoledronic acid) or denosumab, a biologic agent for five years. Continuing treatment after the initial five years may be beneficial for some patients and may be appropriate after reassessing the risks and benefits of continuing therapy.
  • Bisphosphonates are also recommended in men with osteoporosis to reduce fracture risk.
  • Bone density monitoring during the five-year treatment period is not recommended due to lack of evidence of the benefit of monitoring.
  • Use of hormone-replacement therapy (HRT), either estrogen alone or estrogen + progestin or raloxifene for the treatment of osteoporosis in women is not recommended. The serious adverse effects of estrogen treatment such as increased risk for cerebrovascular accidents and venous thromboembolic events outweigh the potential benefits.
To Read More or Comment, Click Here
Top News
Practice Updates
A new clinical severity staging system for patients with nonmetastatic papillary thyroid carcinoma
Women with HIV at four-fold higher risk of PTSD
Study suggests PCOS may be an autoimmune disorder
White cell count may predict ischemia after subarachnoid hemorrhage
Bystander CPR improves outcomes in out-of-hospital cardiac arrest
Effects of patient characteristics and different oral antidiabetic agents on various outcomes in diabetic patients initiating insulin glargine
Comparing postprandial renal hemodynamic effect of lixisenatide and insulin glulisine in diabetes patients on insulin-glargine
Evaluating the efficacy of omarigliptin in patients with type 2 diabetes
Metformin may reduce the risk of colorectal neoplasia
Incidence of diabetic ketoacidosis in new users of SGLT2 inhibitors and non-SGLT2 inhibitors: The first observational study
eMedi Humor
Medicolegal Corner
eMedi Quiz

1. Slick's maneuver is not required.
2. Pre-oxygenation is mandatory.
3. Suxamethonium is contraindicated.
4. Patient is mechanically ventilated before end tracheal incubation.
Webcasts 
Lifestyle Updates
 
Inspirational Story 1: The Midas Touch
Inspirational Story 2. Keep Marketing You 
Press Release
Osteoarthritis prevalence showing an upward trend in India
  • India expected to become the osteoarthritis capital by 2025
  • Weight loss key to managing this condition
New Delhi, 10 May 2017: Statistics indicate that India records more than 10 million cases of osteoarthritis on an annual basis. With over 60 million cases, the country is expected to turn into the osteoarthritis capital of the world by 2025. Osteoarthritis is the most common musculoskeletal disorder with major health and socioeconomic impact in older people. It usually progresses slowly, but some patients experience a more rapid progression.

Osteoarthritis is also called the degenerative joint disease or degenerative arthritis, and can affect any joint. However, it mostly affects the knees, hips, lower back, neck, and small joints of the fingers. Medication and .
To Read More or Comment, Click Here
IMA Updates